Effects of a herbal extract on the bone density, strength and markers of bone turnover of mature ovariectomized rats

American Journal of Chinese Medicine

Volumn 31, Issue 1, 2003, Pages 87-101

  Xu, Min ^a,c   Dick, Ian M ^a   Day, Robert ^a   Randall, Drew ^b   Prince, Richard L ^a,d  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Western Australian Centre for Pathology and Medical Research   (Australia)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Bone Marker; Bone Mineral Density; Bone Strength; Herb Medicine; Ovariectomized Rat

Indexed keywords

ALBUMIN; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; ESTROGEN; HERBACEOUS AGENT; PHOSPHORUS; PLANT EXTRACT; PYRIDINOLINE; ALKALINE PHOSPHATASE; AMINO ACID; BIOLOGICAL MARKER;

ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE STRENGTH; BONE STRESS; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHINESE HERB; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN DEFICIENCY; FEMALE; FEMUR; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; PHOSPHATE BLOOD LEVEL; RAT; SPINE; TIBIA; UTERUS WEIGHT; YOUNG MODULUS; ANIMAL; BLOOD; BONE REMODELING; HISTOLOGY; ORGAN SIZE; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; URINE; UTERUS;

ALKALINE PHOSPHATASE; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CREATININE; DRUGS, CHINESE HERBAL; ESTROGENS; FEMALE; FEMUR; ORGAN SIZE; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SPINE; TIBIA; UTERUS;

EID: 0041881892     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X0300076X     Document Type: Article

References (42)

1. Bonjour, J.P., P. Ammann and R. Rizzoli. Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines. Osteoporos. Int. 9: 379-393, 1999.
2. Center, J.R., T.V. Nguyen, D. Schneider, P.N. Sambrook and J.A. Eisman. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353: 878-882, 1999.
3. Christiansen, C. and B.J. Riis. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern. Br. J. Obstet. Gynaecol. 97: 1087-1092, 1990.
4. Colditz, G.A. Estrogen replacement therapy for breast cancer patients. Oncology 11: 1491-1494, 1497, 1997.
5. Cooper, C. The crippling consequences of fractures and their impact on quality of life. Am. J. Med. 103: 12S-17S, 1997.
6. Draper, C.R., M.J. Edel, I.M. Dick, A.G. Randall, G.B. Martin and R.L. Prince. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr. 127: 1795-1799, 1997.
7. Fanti, P., M.C. Monier-Faugere, Z. Geng, J. Schmidt, P.E. Morris, D. Cohen and H.H. Malluche. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos. Int. 8: 274-281, 1998.
8. Frolik, C.A., H.U. Bryant, E.G. Black, D.E. Magee and S. Chandrasekhar. Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifen, estrogen, and alendronate. Bone 18: 621-627, 1996.
9. Garnero, P. and P.D. Delmas. Osteoporosis. Endocrinol. Metab. Clin. North. Am. 26: 913-936, 1997.
10. Gibaldi, M. Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy? J. Clin. Pharmacol. 37: 1087-1099, 1997.
11. Hall, S.E., R.A. Criddle, T.L. Comito and R.L. Prince. A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int. 9: 508-515, 1999.
12. Hans, D., T. Fuerst, T. Lang, S. Majumdar, Y. Lu, H.K. Genant and C. Gluer. How can we measure bone quality? Baillieres. Clin. Rheumatol. 11: 495-515, 1997.
13. Ishida, H., T. Uesugi, K. Hirai, T. Toda, H. Nukaya, K. Yokotsuka and K. Tsuji. Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol. Pharm. Bull. 21: 62-66, 1998.
14. Ji, L. and Z.L. Xu. Review of constituents in fruits of Psoralea corylifoli. Chin. J. Materia Medica 20: 120-122, 1995.
15. Jiang, Y., J. Zhao, H.K. Genant, J. Dequeker and P. Geusens. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats. J. Bone. Miner. Res. 12: 820-831, 1997.
16. Kalu, D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15: 175-191, 1991.
17. Kalu, D.N., E. Salerno, C.C. Liu, R. Echon, M. Ray, M. Garza-Zapata and B.W. Hollis. A comparative study of the actions of tamoxifen, estrogen and progesterone in the ovariectomized rat. Bone Miner. 15: 109-123, 1991.
18. Ke, H.Z., H.K. Chen, H. Qi, C.M. Pirie, H.A. Simmons, Y.F. Ma, W.S. Jee and D.D. Thompson. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Bone 17: 491-496, 1995.
19. Keenan, M.J., M. Hegsted, K.L. Jones, J.P. Delany, J.C. Kime, L.E. Melancon, R.T. Tulley and K.D. Hong. Comparison of bone density measurement techniques: DXA and Archimedes' principle. J. Bone. Miner. Res. 12: 1903-1907, 1997.
20. Li, X., M. Takahashi, K. Kushida and T. Inoue. The preventive and interventional effects of raloxifene analog (LY117018 HCL) on osteopenia in ovariectomized rats. J. Bone. Miner. Res. 13: 1005-1010, 1998.
21. Lu, P.W., J.N. Briody, R. Howman-Giles, A. Trube and C.T. Cowell. DXA for bone density measurement in small rats weighing 150-250 grams. Bone 15: 199-202, 1994.
22. Mitlak, B.H., D. Schoenfeld and R.M. Neer. Accuracy, precision, and utility of spine and whole-skeleton mineral measurements by DXA in rats. J. Bone. Miner. Res. 9: 119-126, 1994.
23. Notelovitz, M. Estrogen therapy and osteoporosis: principles and practice. Am. J. Med. Sci. 313: 2-12, 1997.
24. Nuttall, M.E., J.N. Bradbeer, G.B. Stroup, D.P. Nadeau, S.J. Hoffman, H. Zhao, S. Rehm and M. Gowen. Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats. Endocrinology 139: 5224-5234, 1998.
25. Ohshima, Y., T. Okuyama, K. Takahashi, T. Takizawa and S. Shibata. Isolation and high performance liquid chromatography (HPLC) of isoflavonoids from the Pueraria root. Planta. Med. 54: 250-254, 1988.
26. Orwoll, E.S. and S.K. Oviatt. Longitudinal precision of dual-energy x-ray absorptiometry in a multicenter study. The Nafarelin/Bone Study Group. J. Bone. Miner. Res. 6: 191-197, 1991.
27. Ott, S.M. When bone mass fails to predict bone failure. Calcif. Tissue Int. 53(Suppl. 1): S7-S13, 1993.
28. Prince, R.L., M. Smith, I.M. Dick, R.L. Price, P.G. Webb, N.K. Henderson and M.M Harris. Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. N. Engl. J. Med. 325: 1189-1195, 1991.
29. Randall, A.G., G.N. Kent, P. Garcia-Webb, C.I. Bhagat, D.J. Pearce, D.H. Gutteridge, R.L. Prince, G. Stewart, B. Stuckey, R.K. Will, R.W. Retallack, R.I. Price and L. Ward. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline crosslinks. J. Bone. Miner. Res. 11: 1176-1184, 1996.
30. Recker, R.R. Low bone mass may not be the only cause of skeletal fragility in osteoporosis. Proc. Soc. Exp. Biol. Med. 191: 272-274, 1989.
31. Rozenberg, S., J. Vandromme, J. Neve, A. Aguilera, A. Muregancuro, A. Peretz, J. Kinthaert and H. Ham. Precision and accuracy of in vivo bone mineral measurement in rats using dual-energy X-ray absorptiometry. Osteoporos. Int. 5: 47-53, 1995.
32. Sato, M., J. Kim, L.L. Short, C.W. Slemenda and H.U. Bryant. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats. J. Pharmacol. Exp. Ther. 272: 1252-1259, 1995.
33. Shen, V., R. Birchman, R. Xu, R. Lindsay and D.W. Dempster. Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen- and/or dietary calcium-deficient rats. Bone 16: 149-156, 1995.
34. Toda, S. and Y. Shirataki. Inhibitory effects of isoflavones on lipid peroxidation by reactive oxygen species. Phytother. Res. 13: 163-165, 1999.
35. Tong, G.H., B.S. Zhang, L. Su, Z.Y. Liu and B.H. Yu. Epidemiological investigation on senile osteoporosis in rural areas. Chin. J. Osteoporosis 2: 81-82, 1996.
36. Wang, C.Y., H.Y. Huang, K.L. Kuo and Y.Z. Hsieh. Analysis of Puerariae radix and its medicinal preparations by capillary electrophoresis. J. Chromatogr. A. 802: 225-231, 1998.
37. Whitehead, M. and V. Godfree. Venous thrombo-embolism and hormone replacement therapy. Baillieres. Clin. Obstet. Gynaecol. 11: 587-599, 1997.
38. Wronski, T.J., C.C. Walsh and L.A. Ignaszewski. Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7: 119-123, 1986.
39. Wronski, T.J., L.M. Dann, K.S. Scott and L.R. Crooke. Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 125: 810-816, 1989.
40. Wronski, T.J., C.F. Yen, K.W. Burton, R.C. Mehta, P.S. Newman, E.E. Soltis and P.P. DeLuca. Skeletal effects of calcitonin in ovariectomized rats. Endocrinology 129: 2246-2250, 1991.
41. Xu, M., Q.S. Liu and X.L. Li. Dual-energy X-ray absorptiometry of the effect of Migu Jian on bone loss in ovariectomized rats. J. Guangzhou Univ. T.C.M. 11: 223-225, 1994.
42. Zhu, H.M., Z.S. Wang, S.Y. Chen, X.Y. Zhu, S.Z. Xie, M.L. Zhou, W.R. Chen, Z.M. Yang and L. Liu. A survey and analysis of incidence and relevant factors of osteoporosis in the elderly (with report of 2041 cases). Natl. Med. J. Chin. 70: 248-251, 1990.